Reckitt Benckiser has said the strategic review of its pharmaceuticals business is still in progress and it will update investors over the course of 2014.

In October 2013, the company said it was considering all options for the business, which could include selling it, spinning it off, or keeping it.

Regarding acquisitions, CEO Rakesh Kapoor said Reckitt would continue to be active in the consumer health space, but declined to comment specifically on reports that consumer companies have approached U.S. drug maker Merck & Co about its consumer business.